‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have revolutionised oncology and are now standard‐of‐care for the treatment of a wide variety of solid neoplasms. However, tumour responses remain unpredictable, experienced by only a minority of ICI recipients across malignancy types. Therefore, there is an urgen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunjur, Ashray, Manrique‐Rincón, Andrea J, Klein, Oliver, Behren, Andreas, Lawley, Trevor D, Welsh, Sarah J, Adams, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Invited Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320825/
https://www.ncbi.nlm.nih.gov/pubmed/35394069
http://dx.doi.org/10.1002/path.5907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320825/
https://www.ncbi.nlm.nih.gov/pubmed/35394069
http://dx.doi.org/10.1002/path.5907

Ejemplares similares